Income Statement Shanghai RAAS Blood Products Co., Ltd.

Equities

002252

CNE100000C31

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 13/05/2026			5-day change	1st Jan Change
5.610 ^CNY	-0.88%		+0.72%	-11.51%

04-28	Shanghai RAAS Blood Products Q1 net profit down 44.2% Y/Y	RE
04-28	Shanghai RAAS Blood Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

6e.AVWtYk6eVp6loMfDxf6wwEr_enM9o2a9Yl1IXuwmQ4Q.MGHaDhGpDNzB6KiRoM-DgyOWHxFIygXuNgVwD7ptAN5oMPlQBtkzy8rThg

Published financial data: SHANGHAI RAAS BLOOD PRODUCTS CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	4.28B	6.57B	7.96B	8.17B	7.34B
Other Revenues, Total	3.01M	1.32M	1.57M	2.85M	8.43M
Total Revenues	4.29B	6.57B	7.96B	8.18B	7.35B
Cost of Goods Sold, Total	2.07B	3.68B	4.73B	4.87B	4.66B
Gross Profit	2.22B	2.89B	3.23B	3.3B	2.69B
Selling General & Admin Expenses, Total	617M	706M	713M	868M	804M
Provision for Bad Debts	-11.97M	15.19M	-5.3M	43.64M	20.41M
R&D Expenses	129M	146M	174M	251M	223M
Other Operating Expenses	23.05M	32.81M	31.52M	48.65M	46.54M
Other Operating Expenses, Total	757M	900M	913M	1.21B	1.09B
Operating Income	1.46B	1.99B	2.32B	2.09B	1.6B
Interest Expense, Total	-472K	-263K	-120K	-225K	-44.11M
Interest And Investment Income	466M	511M	135M	634M	423M
Net Interest Expenses	466M	510M	135M	634M	378M
Currency Exchange Gains (Loss)	11.28M	-56.55M	-43.34M	-85.01M	16.79M
Other Non Operating Income (Expenses)	-1.91M	-1.42M	-421K	-75.1K	-11.27M
EBT, Excl. Unusual Items	1.94B	2.44B	2.41B	2.64B	1.98B
Impairment of Goodwill	-361M	-197M	-	-	-94.02M
Gain (Loss) On Sale Of Investments	-42.76M	18.38M	-197M	-	-
Gain (Loss) On Sale Of Assets	-1.35M	227K	-12.49K	-1.61M	21.16M
Asset Writedown	-9.26M	-2.47M	-4.43M	-13.23M	68.97K
Other Unusual Items	16.54M	13.11M	-2.37M	-7.08M	-1.73M
EBT, Incl. Unusual Items	1.54B	2.27B	2.2B	2.62B	1.91B
Income Tax Expense	250M	401M	427M	426M	329M
Earnings From Continuing Operations	1.29B	1.87B	1.78B	2.19B	1.58B
Net Income to Company	1.29B	1.87B	1.78B	2.19B	1.58B
Minority Interest	5.56M	7.09M	2.04M	-499K	419K
Net Income - (IS)	1.29B	1.88B	1.78B	2.19B	1.58B
Net Income to Common Incl Extra Items	1.29B	1.88B	1.78B	2.19B	1.58B
Net Income to Common Excl. Extra Items	1.29B	1.88B	1.78B	2.19B	1.58B
Per Share Items
Net EPS - Basic	0.19	0.28	0.27	0.33	0.24
Basic EPS - Continuing Operations	0.19	0.28	0.27	0.33	0.24
Basic Weighted Average Shares Outstanding	6.74B	6.74B	6.69B	6.65B	6.58B
Net EPS - Diluted	0.19	0.28	0.27	0.33	0.24
Diluted EPS - Continuing Operations	0.19	0.28	0.27	0.33	0.24
Diluted Weighted Average Shares Outstanding	6.74B	6.74B	6.69B	6.65B	6.58B
Normalized Basic EPS	0.18	0.23	0.23	0.25	0.19
Normalized Diluted EPS	0.18	0.23	0.23	0.25	0.19
Dividend Per Share	0.03	0.03	0.03	0.07	0.05
Payout Ratio	13.02	10.04	11.36	20.05	16.4
Supplemental Items
EBITDA	1.61B	2.17B	2.47B	2.29B	1.82B
EBITA	1.47B	2B	2.32B	2.15B	1.64B
EBIT	1.46B	1.99B	2.32B	2.09B	1.6B
EBITDAR	1.62B	2.17B	2.48B	2.31B	1.84B
Total Revenues (As Reported)	4.29B	6.57B	7.96B	8.18B	-
Effective Tax Rate - (Ratio)	16.25	17.62	19.36	16.27	17.26
Current Domestic Taxes	260M	381M	424M	422M	-
Total Current Taxes	260M	381M	424M	422M	358M
Deferred Domestic Taxes	-9.67M	19.62M	2.88M	3.84M	-
Total Deferred Taxes	-9.67M	19.62M	2.88M	3.84M	-28.98M
Normalized Net Income	1.22B	1.53B	1.51B	1.65B	1.24B
Interest Capitalized	-	-	-	-	443K
Interest on Long-Term Debt	442K	263K	120K	225K	771K
Non-Cash Pension Expense	343K	896K	50.41M	2.06M	3.47M
Supplemental Operating Expense Items
Advertising Expense	170M	193M	143M	193M	109M
Selling and Marketing Expenses	306M	373M	334M	408M	335M
General and Administrative Expenses	311M	333M	379M	460M	469M
Research And Development Expense From Footnotes	129M	146M	174M	251M	223M
Net Rental Expense, Total	4.91M	8.42M	8.98M	13.11M	23.41M
Imputed Operating Lease Interest Expense	2.32M	2.94M	3M	2.42M	4.26M
Imputed Operating Lease Depreciation	2.59M	5.48M	5.98M	10.69M	19.16M
Stock-Based Comp., R&D Exp. (Total)	-	-	4.48M	10.17M	5.81M
Stock-Based Comp., S&M Exp. (Total)	-	-	2.17M	5.3M	731K
Stock-Based Comp., G&A Exp. (Total)	-	-	12.72M	33.09M	12.02M
Stock-Based Comp., Other (Total)	-	-	2.23M	5.21M	1.24M
Total Stock-Based Compensation	-	-	21.61M	53.78M	19.8M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	2.75B	3.98B	4B	2.98B	1.4B
Short Term Investments	-	-	-	-	705M
Trading Asset Securities, Total	219M	238M	197M	-	-
Total Cash And Short Term Investments	2.97B	4.22B	4.2B	2.98B	2.11B
Accounts Receivable, Total	650M	915M	774M	1.81B	2.22B
Other Receivables	1.21M	2.02M	8.22M	3.31M	92.81M
Total Receivables	651M	917M	782M	1.81B	2.32B
Inventory	3.17B	3.27B	3.67B	4.29B	5.37B
Prepaid Expenses	143K	103K	-	7.7M	58.63M
Other Current Assets, Total	81.69M	71.41M	27.28M	161M	104M
Total Current Assets	6.87B	8.47B	8.68B	9.26B	9.95B
Gross Property Plant And Equipment	2.27B	2.42B	2.7B	3.26B	4.13B
Accumulated Depreciation	-991M	-1.13B	-1.25B	-1.34B	-1.46B
Net Property Plant And Equipment	1.28B	1.28B	1.45B	1.92B	2.66B
Long-term Investments	13.88B	15.7B	16.18B	16.78B	16B
Goodwill	4.9B	4.7B	5.07B	5.07B	8.2B
Other Intangibles, Total	163M	175M	234M	485M	733M
Deferred Tax Assets Long-Term	104M	83.55M	89.81M	75.14M	93.52M
Deferred Charges Long-Term	28.97M	25.78M	21.29M	28.47M	29.73M
Other Long-Term Assets, Total	11.54M	13M	205M	12.22M	109M
Total Assets	27.24B	30.46B	31.93B	33.63B	37.78B
Liabilities
Accounts Payable, Total	956M	1.13B	1.64B	1.08B	343M
Accrued Expenses, Total	210M	275M	289M	347M	362M
Short-term Borrowings	-	-	-	-	1.31B
Current Portion of Long-Term Debt	-	-	-	-	108M
Current Portion of Leases	4.09M	1.98M	411K	4.61M	3.41M
Current Income Taxes Payable	53.53M	91.03M	94.57M	25.94M	45.35M
Unearned Revenue Current, Total	28.69M	91.76M	22.64M	4.69M	3.54M
Other Current Liabilities	54.36M	34.54M	195M	193M	562M
Total Current Liabilities	1.31B	1.62B	2.24B	1.65B	2.74B
Long-Term Debt	-	-	-	-	2.47B
Long-Term Leases	4.16M	1.85M	1.49M	12.99M	10.39M
Unearned Revenue Non Current	15.2M	12.77M	9.49M	10.96M	13.61M
Deferred Tax Liability Non Current	6.44M	5.34M	16.02M	14.82M	44.89M
Other Non Current Liabilities	-	-	7.06M	-	46.9M
Total Liabilities	1.33B	1.64B	2.28B	1.69B	5.33B
Common Stock, Total	6.74B	6.74B	6.65B	6.64B	6.64B
Additional Paid In Capital	14.56B	14.56B	13.81B	14.06B	14.04B
Retained Earnings	5.84B	7.53B	9.11B	10.86B	12.12B
Treasury Stock	-	-	-183M	-77.18M	-523M
Comprehensive Income and Other	-1.24B	-15.72M	256M	449M	181M
Total Common Equity	25.9B	28.82B	29.63B	31.93B	32.46B
Minority Interest	1.72M	-5.37M	15.86M	14.46M	-
Total Equity	25.9B	28.81B	29.65B	31.94B	32.46B
Total Liabilities And Equity	27.24B	30.46B	31.93B	33.63B	37.78B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	6.74B	6.74B	6.6B	6.62B	6.56B
ECS Total Common Shares Outstanding	6.74B	6.74B	6.6B	6.62B	6.56B
Book Value / Share	3.84	4.28	4.49	4.83	4.95
Tangible Book Value	20.84B	23.94B	24.33B	26.37B	23.52B
Tangible Book Value Per Share	3.09	3.55	3.68	3.99	3.59
Total Debt	8.25M	3.82M	1.91M	17.59M	3.9B
Net Debt	-2.96B	-4.21B	-4.2B	-2.97B	1.8B
Debt Equivalent Oper. Leases	39.25M	67.32M	71.85M	105M	187M
Minority Interest, Total (Incl. Fin. Div)	1.72M	-5.37M	15.86M	14.46M	-
Equity Method Investments, Total	13.28B	14.93B	15.06B	15.38B	15.27B
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	588M	559M	556M	622M	892M
Inventories - Work In Process, Total	889M	994M	900M	797M	981M
Inventories - Finished Goods, Total	1.71B	1.73B	2.24B	2.91B	3.55B
Buildings, Total	1.15B	1.2B	1.34B	1.66B	2.19B
Machinery, Total	1.07B	1.13B	1.22B	1.29B	1.52B
Full Time Employees	2.97K	3.12K	3.25K	3.35K	4.04K
Accumulated Allowance for Doubtful Accounts (Supple)	80.76M	95.95M	90.65M	134M	154M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	1.29B	1.88B	1.78B	2.19B	1.58B
Depreciation & Amortization - CF	143M	172M	151M	144M	178M
Amortization of Goodwill and Intangible Assets - (CF)	10.58M	10.45M	7.51M	56.99M	47.69M
Depreciation & Amortization, Total	154M	182M	159M	201M	226M
Amortization of Deferred Charges, Total - (CF)	15.07M	12.74M	13.52M	16M	15.65M
(Gain) Loss From Sale Of Asset	1.35M	-227K	12.49K	1.61M	-21.16M
(Gain) Loss on Sale of Investments - (CF)	-368M	-18.38M	197M	-514M	-353M
Asset Writedown & Restructuring Costs	370M	199M	4.31M	13.23M	92.79M
Stock-Based Compensation (CF)	-	-	21.61M	53.78M	19.8M
Provision and Write-off of Bad Debts	-10.83M	16.38M	-5.22M	42.98M	20.41M
Other Operating Activities, Total	-25.1M	-507M	-89.3M	-87.48M	33.83M
Change In Accounts Receivable	-75.16M	-287M	163M	-1.23B	-387M
Change In Inventories	-1.01B	-106M	-418M	-639M	-758M
Change In Accounts Payable	961M	334M	449M	-543M	-766M
Change In Deferred Taxes	-9.67M	19.62M	2.88M	6.93M	-28.98M
Change in Other Net Operating Assets	-	-	-	-	-
Cash from Operations	1.29B	1.73B	2.28B	-482M	-329M
Capital Expenditure	-205M	-226M	-451M	-407M	-385M
Sale of Property, Plant, and Equipment	3.19M	2.24M	2.33M	334K	3.19M
Cash Acquisitions	-	-	-441M	-34M	-3.7B
Divestitures	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-610M	-947M	142M	-775M	1.83B
Other Investing Activities, Total	80.11M	39.97M	76.84M	300M	5.42M
Cash from Investing	-731M	-1.13B	-671M	-916M	-2.25B
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	-	-	-	-	3.66B
Total Debt Issued	-	-	-	-	3.66B
Short Term Debt Repaid, Total	-7.74M	-	-	-	-
Long-Term Debt Repaid, Total	-4.21M	-5.73M	-2.04M	-4.65M	-302M
Total Debt Repaid	-11.95M	-5.73M	-2.04M	-4.65M	-302M
Issuance of Common Stock	-	-	113M	15.57M	-
Repurchase of Common Stock	-	-	-1B	-2.27M	-478M
Common Dividends Paid	-169M	-189M	-202M	-440M	-259M
Common & Preferred Stock Dividends Paid	-169M	-189M	-202M	-440M	-259M
Other Financing Activities, Total	1.19M	1.09M	-43.13M	-33.2M	-54.5M
Cash from Financing	-179M	-193M	-1.13B	-464M	2.57B
Foreign Exchange Rate Adjustments	-2.26M	11.75M	-3.31M	1.32M	16.79M
Net Change in Cash	382M	414M	470M	-1.86B	3.26M
Supplemental Items
Cash Interest Paid	29.68K	-	-	-	-
Cash Income Tax Paid (Refund)	339M	594M	645M	826M	621M
Levered Free Cash Flow	749M	1.18B	1.59B	-1.22B	-1.05B
Unlevered Free Cash Flow	749M	1.18B	1.59B	-1.22B	-1.03B
Change In Net Working Capital	129M	31.87M	-403M	2.4B	1.9B
Net Debt Issued / Repaid	-11.95M	-5.73M	-2.04M	-4.65M	3.36B

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	3.47	4.31	4.64	3.99	2.79
Return on Total Capital	3.58	4.54	4.95	4.25	2.92
Return On Equity %	5.05	6.85	6.08	7.12	4.9
Return on Common Equity	5.07	6.87	6.09	7.13	4.9
Margin Analysis
Gross Profit Margin %	51.75	43.99	40.54	40.41	36.61
SG&A Margin	14.38	10.76	8.95	10.61	10.94
EBITDA Margin %	37.56	32.99	31.05	28.04	24.74
EBITA Margin %	34.35	30.44	29.18	26.3	22.37
EBIT Margin %	34.1	30.29	29.08	25.6	21.72
Income From Continuing Operations Margin %	30.06	28.52	22.32	26.83	21.46
Net Income Margin %	30.19	28.63	22.34	26.82	21.46
Net Avail. For Common Margin %	30.19	28.63	22.34	26.82	21.46
Normalized Net Income Margin	28.37	23.34	18.92	20.19	16.85
Levered Free Cash Flow Margin	17.46	17.97	20.01	-14.96	-14.35
Unlevered Free Cash Flow Margin	17.47	17.97	20.01	-14.95	-13.98
Asset Turnover
Asset Turnover	0.16	0.23	0.26	0.25	0.21
Fixed Assets Turnover	3.42	5.13	5.83	4.85	3.21
Receivables Turnover (Average Receivables)	6.97	8.39	9.43	6.33	3.64
Inventory Turnover (Average Inventory)	0.78	1.14	1.37	1.22	0.96
Short Term Liquidity
Current Ratio	5.26	5.22	3.86	5.6	3.64
Quick Ratio	2.77	3.16	2.22	2.9	1.62
Operating Cash Flow to Current Liabilities	0.99	1.06	1.01	-0.29	-0.12
Days Sales Outstanding (Average Receivables)	52.38	43.5	38.72	57.86	100.3
Days Outstanding Inventory (Average Inventory)	470.73	319.64	267.33	298.95	378.41
Average Days Payable Outstanding	61.84	100.89	98.58	90.78	45.2
Cash Conversion Cycle (Average Days)	461.26	262.25	207.47	266.03	433.51
Long Term Solvency
Total Debt/Equity	0.03	0.01	0.01	0.06	12.03
Total Debt / Total Capital	0.03	0.01	0.01	0.06	10.74
LT Debt/Equity	0.02	0.01	0	0.04	7.65
Long-Term Debt / Total Capital	0.02	0.01	0	0.04	6.83
Total Liabilities / Total Assets	4.89	5.4	7.14	5.03	14.1
EBIT / Interest Expense	3.1K	7.56K	19.34K	9.31K	36.18
EBITDA / Interest Expense	3.42K	8.25K	20.67K	10.2K	41.3
(EBITDA - Capex) / Interest Expense	2.99K	7.39K	16.91K	8.39K	32.58
Total Debt / EBITDA	0.01	0	0	0.01	2.14
Net Debt / EBITDA	-1.83	-1.94	-1.7	-1.29	0.99
Total Debt / (EBITDA - Capex)	0.01	0	0	0.01	2.72
Net Debt / (EBITDA - Capex)	-2.1	-2.17	-2.07	-1.57	1.25
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	55.26	53.16	21.27	2.67	-10.13
Gross Profit, 1 Yr. Growth %	30.35	30.21	11.76	2.33	-18.58
EBITDA, 1 Yr. Growth %	37.38	34.05	13.99	-7.43	-20.92
EBITA, 1 Yr. Growth %	40.54	35.26	16.06	-7.63	-23.76
EBIT, 1 Yr. Growth %	43.39	36.03	16.46	-9.63	-23.75
Earnings From Cont. Operations, 1 Yr. Growth %	-2.25	45.31	-5.1	23.42	-28.13
Net Income, 1 Yr. Growth %	-2.21	45.24	-5.35	23.25	-28.1
Normalized Net Income, 1 Yr. Growth %	20.41	26.04	-1.7	9.55	-25.01
Diluted EPS Before Extra, 1 Yr. Growth %	-8.09	46.8	-4.66	22.22	-27.35
Accounts Receivable, 1 Yr. Growth %	11.95	40.94	-15.44	133.87	22.81
Inventory, 1 Yr. Growth %	46.7	3.01	12.18	17.06	25
Net Property, Plant and Equip., 1 Yr. Growth %	4.05	0.23	13.35	32.33	38.5
Total Assets, 1 Yr. Growth %	6.84	11.83	4.83	5.33	12.34
Tangible Book Value, 1 Yr. Growth %	5.84	14.88	1.61	8.39	-10.78
Common Equity, 1 Yr. Growth %	3.1	11.26	2.83	7.74	1.66
Cash From Operations, 1 Yr. Growth %	10.71	33.35	32.01	-121.16	-31.81
Capital Expenditures, 1 Yr. Growth %	-18.73	10.32	99.71	-9.68	-5.48
Levered Free Cash Flow, 1 Yr. Growth %	32.56	57.64	35.03	-176.74	-13.75
Unlevered Free Cash Flow, 1 Yr. Growth %	32.56	57.6	35.02	-176.73	-15.99
Dividend Per Share, 1 Yr. Growth %	12	7.14	0	133.33	-31
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	28.79	54.21	36.29	11.58	-3.94
Gross Profit, 2 Yr. CAGR %	16	30.28	20.63	6.94	-8.72
EBITDA, 2 Yr. CAGR %	24.18	35.94	23.69	2.81	-14.33
EBITA, 2 Yr. CAGR %	26.37	38.13	25.38	3.63	-15.97
EBIT, 2 Yr. CAGR %	27.74	39.67	25.87	2.59	-16.99
Earnings From Cont. Operations, 2 Yr. CAGR %	45.85	19.18	17.43	8.23	-5.82
Net Income, 2 Yr. CAGR %	45.93	19.18	17.24	8.01	-5.86
Normalized Net Income, 2 Yr. CAGR %	48.42	23.19	11.31	3.77	-9.36
Diluted EPS Before Extra, 2 Yr. CAGR %	25.83	16.15	18.3	8.77	-5.77
Accounts Receivable, 2 Yr. CAGR %	-13.2	25.61	9.17	40.63	69.48
Inventory, 2 Yr. CAGR %	28.79	22.93	7.5	14.59	20.96
Net Property, Plant and Equip., 2 Yr. CAGR %	6.1	2.12	6.59	22.47	35.38
Total Assets, 2 Yr. CAGR %	51.59	9.3	8.27	5.08	8.78
Tangible Book Value, 2 Yr. CAGR %	87.87	10.27	8.04	4.95	-1.66
Common Equity, 2 Yr. CAGR %	50.22	7.1	6.96	5.25	4.65
Cash From Operations, 2 Yr. CAGR %	21.77	21.5	32.68	-47.15	-62.01
Capital Expenditures, 2 Yr. CAGR %	14.94	-5.31	48.43	34.3	-7.61
Levered Free Cash Flow, 2 Yr. CAGR %	20.18	44.56	45.9	1.79	-18.64
Unlevered Free Cash Flow, 2 Yr. CAGR %	20.08	44.54	45.87	1.78	-19.71
Dividend Per Share, 2 Yr. CAGR %	67.33	9.54	3.51	52.75	26.89
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	33.45	36.45	42.34	24.01	3.82
Gross Profit, 3 Yr. CAGR %	23.19	20.55	23.79	14.19	-2.35
EBITDA, 3 Yr. CAGR %	40.22	27.53	28.24	12.36	-5.72
EBITA, 3 Yr. CAGR %	47.4	29.43	30.41	13.3	-6.36
EBIT, 3 Yr. CAGR %	49.86	30.44	31.46	12.71	-7.07
Earnings From Cont. Operations, 3 Yr. CAGR %	-5.41	45.67	10.47	19.4	-5.58
Net Income, 3 Yr. CAGR %	-5.18	45.7	10.37	19.21	-5.69
Normalized Net Income, 3 Yr. CAGR %	68.73	40.55	14.26	10.72	-6.88
Diluted EPS Before Extra, 3 Yr. CAGR %	-15.06	32.46	8.75	20.2	-4.92
Accounts Receivable, 3 Yr. CAGR %	-12.09	2.02	10.09	40.73	34.42
Inventory, 3 Yr. CAGR %	23.57	19.55	19.24	10.6	17.96
Net Property, Plant and Equip., 3 Yr. CAGR %	4.32	4.1	5.74	14.56	27.6
Total Assets, 3 Yr. CAGR %	33.73	36.97	7.79	7.28	7.45
Tangible Book Value, 3 Yr. CAGR %	59.21	59.46	7.3	8.16	-0.58
Common Equity, 3 Yr. CAGR %	33.54	35.91	5.66	7.22	4.04
Cash From Operations, 3 Yr. CAGR %	70.19	25.51	24.91	-28.05	-42.46
Capital Expenditures, 3 Yr. CAGR %	9.24	13.38	21.43	25.78	19.46
Levered Free Cash Flow, 3 Yr. CAGR %	88.26	31.56	41.31	17.77	-3.68
Unlevered Free Cash Flow, 3 Yr. CAGR %	119.37	31.47	41.29	17.75	-4.53
Dividend Per Share, 3 Yr. CAGR %	-	44.22	6.27	35.72	17.2
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	13.01	27.78	34.58	25.9	21.62
Gross Profit, 5 Yr. CAGR %	8.41	18.77	22.16	14.91	9.59
EBITDA, 5 Yr. CAGR %	5.81	19.02	33.45	17.03	9.17
EBITA, 5 Yr. CAGR %	5.79	20.46	38.27	18.45	9.42
EBIT, 5 Yr. CAGR %	5.82	21.09	39.76	18.49	9.38
Earnings From Cont. Operations, 5 Yr. CAGR %	-4.82	17.62	3.14	29.35	3.64
Net Income, 5 Yr. CAGR %	-4.31	17.6	3.22	29.26	3.56
Normalized Net Income, 5 Yr. CAGR %	2.36	16.12	42.87	24.49	4.15
Diluted EPS Before Extra, 5 Yr. CAGR %	-10.45	10.41	-3.02	22.42	3.01
Accounts Receivable, 5 Yr. CAGR %	-8.26	-3.89	-4.13	16	30.82
Inventory, 5 Yr. CAGR %	31.63	23.14	16.87	17.54	19.92
Net Property, Plant and Equip., 5 Yr. CAGR %	1.76	2.79	5.22	11.1	16.72
Total Assets, 5 Yr. CAGR %	15.54	16.07	22.9	23.19	8.19
Tangible Book Value, 5 Yr. CAGR %	29.01	29.59	36.34	34.89	3.62
Common Equity, 5 Yr. CAGR %	17.21	18.25	22.19	22.7	5.26
Cash From Operations, 5 Yr. CAGR %	15.18	45.05	54.06	-11.19	-22.41
Capital Expenditures, 5 Yr. CAGR %	6.77	7.42	23.5	21.33	8.86
Levered Free Cash Flow, 5 Yr. CAGR %	1.53	11.36	70.01	18.73	13.31
Unlevered Free Cash Flow, 5 Yr. CAGR %	0.92	12.84	86.34	18.68	12.7
Dividend Per Share, 5 Yr. CAGR %	-1.37	12.03	-	47.58	14.08